SynthesisArthritis research & therapy2015

Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis.

Anneloes van Walsem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.